Retired Vax Scientist Would
Never Vaccinate His Kids
Sunday, August 16, 2009
Swine flu vaccine could cause deadly nervous disorder
Swine flu vaccine could cause deadly nervous disorder
16/08/2009 15:06:00 admin
Font size:
British medical authorities told clinicians to report each month whether they have seen any cases of Guillain-Barre syndrome, a deadly nervous disorder that could be triggered by swine flu vaccine, which is expected in October, telegraph.co.uk reported today.
Swine flu or H1N1 vaccine proved a fiasco in 1976 when the U.S. health officials rushed out the vaccine following an outbreak of swine flu in military barracks because the virus was found somewhat related to the strain involved in the 1918 flu pandemic that killed millions around the world
News media has reported that in that outbreak, seven soldiers were infected with H1N1 virus and one died after getting H1N1 flu. Ironically, the soldier who died was reportedly the only one who received the vaccine among the seven.
The national vaccination campaign had as many as 40 million people vaccinated and unfortunately many people developed Guillain-Barre syndrome. Twenty-five people died reportedly from the nervous disorder before the immunization program was scrapped.
The following is cited from a U.S. government website to give readers more information on the nervous disorder.
What is Guillain-Barré syndrome?
Guillain-Barré syndrome is a disorder in which the body's immune system attacks part of the peripheral nervous system. The first symptoms of this disorder include varying degrees of weakness or tingling sensations in the legs. In many instances the weakness and abnormal sensations spread to the arms and upper body. These symptoms can increase in intensity until certain muscles cannot be used at all and, when severe, the patient is almost totally paralyzed. In these cases the disorder is life threatening - potentially interfering with breathing and, at times, with blood pressure or heart rate - and is considered a medical emergency. Such a patient is often put on a respirator to assist with breathing and is watched closely for problems such as an abnormal heart beat, infections, blood clots, and high or low blood pressure. Most patients, however, recover from even the most severe cases of Guillain-Barré syndrome, although some continue to have a certain degree of weakness.
Guillain-Barré syndrome can affect anybody. It can strike at any age and both sexes are equally prone to the disorder. The syndrome is rare, however, afflicting only about one person in 100,000. Usually Guillain-Barré occurs a few days or weeks after the patient has had symptoms of a respiratory or gastrointestinal viral infection. Occasionally surgery or vaccinations will trigger the syndrome.
After the first clinical manifestations of the disease, the symptoms can progress over the course of hours, days, or weeks. Most people reach the stage of greatest weakness within the first 2 weeks after symptoms appear, and by the third week of the illness 90 percent of all patients are at their weakest.
What causes Guillain-Barré syndrome?
No one yet knows why Guillain-Barré—which is not contagious—strikes some people and not others. Nor does anyone know exactly what sets the disease in motion.
What scientists do know is that the body's immune system begins to attack the body itself, causing what is known as an autoimmune disease. Usually the cells of the immune system attack only foreign material and invading organisms. In Guillain-Barré syndrome, however, the immune system starts to destroy the myelin sheath that surrounds the axons of many peripheral nerves, or even the axons themselves (axons are long, thin extensions of the nerve cells; they carry nerve signals). The myelin sheath surrounding the axon speeds up the transmission of nerve signals and allows the transmission of signals over long distances.
In diseases in which the peripheral nerves' myelin sheaths are injured or degraded, the nerves cannot transmit signals efficiently. That is why the muscles begin to lose their ability to respond to the brain's commands, commands that must be carried through the nerve network. The brain also receives fewer sensory signals from the rest of the body, resulting in an inability to feel textures, heat, pain, and other sensations. Alternately, the brain may receive inappropriate signals that result in tingling, "crawling-skin," or painful sensations. Because the signals to and from the arms and legs must travel the longest distances they are most vulnerable to interruption. Therefore, muscle weakness and tingling sensations usually first appear in the hands and feet and progress upwards.
When Guillain-Barré is preceded by a viral or bacterial infection, it is possible that the virus has changed the nature of cells in the nervous system so that the immune system treats them as foreign cells. It is also possible that the virus makes the immune system itself less discriminating about what cells it recognizes as its own, allowing some of the immune cells, such as certain kinds of lymphocytes and macrophages, to attack the myelin. Sensitized T lymphocytes cooperate with B lymphocytes to produce antibodies against components of the myelin sheath and may contribute to destruction of the myelin. Scientists are investigating these and other possibilities to find why the immune system goes awry in Guillain-Barré syndrome and other autoimmune diseases. The cause and course of Guillain-Barré syndrome is an active area of neurological investigation, incorporating the cooperative efforts of neurological scientists, immunologists, and virologists.
How is Guillain-Barré syndrome diagnosed?
Guillain-Barré is called a syndrome rather than a disease because it is not clear that a specific disease-causing agent is involved. A syndrome is a medical condition characterized by a collection of symptoms (what the patient feels) and signs (what a doctor can observe or measure). The signs and symptoms of the syndrome can be quite varied, so doctors may, on rare occasions, find it difficult to diagnose Guillain-Barré in its earliest stages.
Several disorders have symptoms similar to those found in Guillain-Barré, so doctors examine and question patients carefully before making a diagnosis. Collectively, the signs and symptoms form a certain pattern that helps doctors differentiate Guillain-Barré from other disorders. For example, physicians will note whether the symptoms appear on both sides of the body (most common in Guillain-Barré) and the quickness with which the symptoms appear (in other disorders, muscle weakness may progress over months rather than days or weeks). In Guillain-Barré, reflexes such as knee jerks are usually lost. Because the signals traveling along the nerve are slower, a nerve conduction velocity (NCV) test can give a doctor clues to aid the diagnosis. In Guillain-Barré patients, the cerebrospinal fluid that bathes the spinal cord and brain contains more protein than usual. Therefore a physician may decide to perform a spinal tap, a procedure in which the doctor inserts a needle into the patient's lower back to draw cerebrospinal fluid from the spinal column.
How is Guillain-Barré treated?
There is no known cure for Guillain-Barré syndrome. However, there are therapies that lessen the severity of the illness and accelerate the recovery in most patients. There are also a number of ways to treat the complications of the disease.
Currently, plasma exchange (sometimes called plasmapheresis) and high-dose immunoglobulin therapy are used. Both of them are equally effective, but immunoglobulin is easier to administer. Plasma exchange is a method by which whole blood is removed from the body and processed so that the red and white blood cells are separated from the plasma, or liquid portion of the blood. The blood cells are then returned to the patient without the plasma, which the body quickly replaces. Scientists still don't know exactly why plasma exchange works, but the technique seems to reduce the severity and duration of the Guillain-Barré episode. This may be because the plasma portion of the blood contains elements of the immune system that may be toxic to the myelin.
In high-dose immunoglobulin therapy, doctors give intravenous injections of the proteins that, in small quantities, the immune system uses naturally to attack invading organisms. Investigators have found that giving high doses of these immunoglobulins, derived from a pool of thousands of normal donors, to Guillain-Barré patients can lessen the immune attack on the nervous system. Investigators don't know why or how this works, although several hypotheses have been proposed.
The use of steroid hormones has also been tried as a way to reduce the severity of Guillain-Barré, but controlled clinical trials have demonstrated that this treatment not only is not effective but may even have a deleterious effect on the disease.
The most critical part of the treatment for this syndrome consists of keeping the patient's body functioning during recovery of the nervous system. This can sometimes require placing the patient on a respirator, a heart monitor, or other machines that assist body function. The need for this sophisticated machinery is one reason why Guillain-Barré syndrome patients are usually treated in hospitals, often in an intensive care ward. In the hospital, doctors can also look for and treat the many problems that can afflict any paralyzed patient - complications such as pneumonia or bed sores.
Often, even before recovery begins, caregivers may be instructed to manually move the patient's limbs to help keep the muscles flexible and strong. Later, as the patient begins to recover limb control, physical therapy begins. Carefully planned clinical trials of new and experimental therapies are the key to improving the treatment of patients with Guillain-Barré syndrome. Such clinical trials begin with the research of basic and clinical scientists who, working with clinicians, identify new approaches to treating patients with the disease.
What is the long-term outlook for those with Guillain-Barré syndrome?
Guillain-Barré syndrome can be a devastating disorder because of its sudden and unexpected onset. In addition, recovery is not necessarily quick. As noted above, patients usually reach the point of greatest weakness or paralysis days or weeks after the first symptoms occur. Symptoms then stabilize at this level for a period of days, weeks, or, sometimes, months. The recovery period may be as little as a few weeks or as long as a few years. About 30 percent of those with Guillain-Barré still have a residual weakness after 3 years. About 3 percent may suffer a relapse of muscle weakness and tingling sensations many years after the initial attack.
Guillain-Barré syndrome patients face not only physical difficulties, but emotionally painful periods as well. It is often extremely difficult for patients to adjust to sudden paralysis and dependence on others for help with routine daily activities. Patients sometimes need psychological counseling to help them adapt.
What research is being done?
Scientists are concentrating on finding new treatments and refining existing ones. Scientists are also looking at the workings of the immune system to find which cells are responsible for beginning and carrying out the attack on the nervous system. The fact that so many cases of Guillain-Barré begin after a viral or bacterial infection suggests that certain characteristics of some viruses and bacteria may activate the immune system inappropriately. Investigators are searching for those characteristics. Certain proteins or peptides in viruses and bacteria may be the same as those found in myelin, and the generation of antibodies to neutralize the invading viruses or bacteria could trigger the attack on the myelin sheath. As noted previously, neurological scientists, immunologists, virologists, and pharmacologists are all working collaboratively to learn how to prevent this disorder and to make better therapies available when it strikes.
16/08/2009 15:06:00 admin
Font size:
British medical authorities told clinicians to report each month whether they have seen any cases of Guillain-Barre syndrome, a deadly nervous disorder that could be triggered by swine flu vaccine, which is expected in October, telegraph.co.uk reported today.
Swine flu or H1N1 vaccine proved a fiasco in 1976 when the U.S. health officials rushed out the vaccine following an outbreak of swine flu in military barracks because the virus was found somewhat related to the strain involved in the 1918 flu pandemic that killed millions around the world
News media has reported that in that outbreak, seven soldiers were infected with H1N1 virus and one died after getting H1N1 flu. Ironically, the soldier who died was reportedly the only one who received the vaccine among the seven.
The national vaccination campaign had as many as 40 million people vaccinated and unfortunately many people developed Guillain-Barre syndrome. Twenty-five people died reportedly from the nervous disorder before the immunization program was scrapped.
The following is cited from a U.S. government website to give readers more information on the nervous disorder.
What is Guillain-Barré syndrome?
Guillain-Barré syndrome is a disorder in which the body's immune system attacks part of the peripheral nervous system. The first symptoms of this disorder include varying degrees of weakness or tingling sensations in the legs. In many instances the weakness and abnormal sensations spread to the arms and upper body. These symptoms can increase in intensity until certain muscles cannot be used at all and, when severe, the patient is almost totally paralyzed. In these cases the disorder is life threatening - potentially interfering with breathing and, at times, with blood pressure or heart rate - and is considered a medical emergency. Such a patient is often put on a respirator to assist with breathing and is watched closely for problems such as an abnormal heart beat, infections, blood clots, and high or low blood pressure. Most patients, however, recover from even the most severe cases of Guillain-Barré syndrome, although some continue to have a certain degree of weakness.
Guillain-Barré syndrome can affect anybody. It can strike at any age and both sexes are equally prone to the disorder. The syndrome is rare, however, afflicting only about one person in 100,000. Usually Guillain-Barré occurs a few days or weeks after the patient has had symptoms of a respiratory or gastrointestinal viral infection. Occasionally surgery or vaccinations will trigger the syndrome.
After the first clinical manifestations of the disease, the symptoms can progress over the course of hours, days, or weeks. Most people reach the stage of greatest weakness within the first 2 weeks after symptoms appear, and by the third week of the illness 90 percent of all patients are at their weakest.
What causes Guillain-Barré syndrome?
No one yet knows why Guillain-Barré—which is not contagious—strikes some people and not others. Nor does anyone know exactly what sets the disease in motion.
What scientists do know is that the body's immune system begins to attack the body itself, causing what is known as an autoimmune disease. Usually the cells of the immune system attack only foreign material and invading organisms. In Guillain-Barré syndrome, however, the immune system starts to destroy the myelin sheath that surrounds the axons of many peripheral nerves, or even the axons themselves (axons are long, thin extensions of the nerve cells; they carry nerve signals). The myelin sheath surrounding the axon speeds up the transmission of nerve signals and allows the transmission of signals over long distances.
In diseases in which the peripheral nerves' myelin sheaths are injured or degraded, the nerves cannot transmit signals efficiently. That is why the muscles begin to lose their ability to respond to the brain's commands, commands that must be carried through the nerve network. The brain also receives fewer sensory signals from the rest of the body, resulting in an inability to feel textures, heat, pain, and other sensations. Alternately, the brain may receive inappropriate signals that result in tingling, "crawling-skin," or painful sensations. Because the signals to and from the arms and legs must travel the longest distances they are most vulnerable to interruption. Therefore, muscle weakness and tingling sensations usually first appear in the hands and feet and progress upwards.
When Guillain-Barré is preceded by a viral or bacterial infection, it is possible that the virus has changed the nature of cells in the nervous system so that the immune system treats them as foreign cells. It is also possible that the virus makes the immune system itself less discriminating about what cells it recognizes as its own, allowing some of the immune cells, such as certain kinds of lymphocytes and macrophages, to attack the myelin. Sensitized T lymphocytes cooperate with B lymphocytes to produce antibodies against components of the myelin sheath and may contribute to destruction of the myelin. Scientists are investigating these and other possibilities to find why the immune system goes awry in Guillain-Barré syndrome and other autoimmune diseases. The cause and course of Guillain-Barré syndrome is an active area of neurological investigation, incorporating the cooperative efforts of neurological scientists, immunologists, and virologists.
How is Guillain-Barré syndrome diagnosed?
Guillain-Barré is called a syndrome rather than a disease because it is not clear that a specific disease-causing agent is involved. A syndrome is a medical condition characterized by a collection of symptoms (what the patient feels) and signs (what a doctor can observe or measure). The signs and symptoms of the syndrome can be quite varied, so doctors may, on rare occasions, find it difficult to diagnose Guillain-Barré in its earliest stages.
Several disorders have symptoms similar to those found in Guillain-Barré, so doctors examine and question patients carefully before making a diagnosis. Collectively, the signs and symptoms form a certain pattern that helps doctors differentiate Guillain-Barré from other disorders. For example, physicians will note whether the symptoms appear on both sides of the body (most common in Guillain-Barré) and the quickness with which the symptoms appear (in other disorders, muscle weakness may progress over months rather than days or weeks). In Guillain-Barré, reflexes such as knee jerks are usually lost. Because the signals traveling along the nerve are slower, a nerve conduction velocity (NCV) test can give a doctor clues to aid the diagnosis. In Guillain-Barré patients, the cerebrospinal fluid that bathes the spinal cord and brain contains more protein than usual. Therefore a physician may decide to perform a spinal tap, a procedure in which the doctor inserts a needle into the patient's lower back to draw cerebrospinal fluid from the spinal column.
How is Guillain-Barré treated?
There is no known cure for Guillain-Barré syndrome. However, there are therapies that lessen the severity of the illness and accelerate the recovery in most patients. There are also a number of ways to treat the complications of the disease.
Currently, plasma exchange (sometimes called plasmapheresis) and high-dose immunoglobulin therapy are used. Both of them are equally effective, but immunoglobulin is easier to administer. Plasma exchange is a method by which whole blood is removed from the body and processed so that the red and white blood cells are separated from the plasma, or liquid portion of the blood. The blood cells are then returned to the patient without the plasma, which the body quickly replaces. Scientists still don't know exactly why plasma exchange works, but the technique seems to reduce the severity and duration of the Guillain-Barré episode. This may be because the plasma portion of the blood contains elements of the immune system that may be toxic to the myelin.
In high-dose immunoglobulin therapy, doctors give intravenous injections of the proteins that, in small quantities, the immune system uses naturally to attack invading organisms. Investigators have found that giving high doses of these immunoglobulins, derived from a pool of thousands of normal donors, to Guillain-Barré patients can lessen the immune attack on the nervous system. Investigators don't know why or how this works, although several hypotheses have been proposed.
The use of steroid hormones has also been tried as a way to reduce the severity of Guillain-Barré, but controlled clinical trials have demonstrated that this treatment not only is not effective but may even have a deleterious effect on the disease.
The most critical part of the treatment for this syndrome consists of keeping the patient's body functioning during recovery of the nervous system. This can sometimes require placing the patient on a respirator, a heart monitor, or other machines that assist body function. The need for this sophisticated machinery is one reason why Guillain-Barré syndrome patients are usually treated in hospitals, often in an intensive care ward. In the hospital, doctors can also look for and treat the many problems that can afflict any paralyzed patient - complications such as pneumonia or bed sores.
Often, even before recovery begins, caregivers may be instructed to manually move the patient's limbs to help keep the muscles flexible and strong. Later, as the patient begins to recover limb control, physical therapy begins. Carefully planned clinical trials of new and experimental therapies are the key to improving the treatment of patients with Guillain-Barré syndrome. Such clinical trials begin with the research of basic and clinical scientists who, working with clinicians, identify new approaches to treating patients with the disease.
What is the long-term outlook for those with Guillain-Barré syndrome?
Guillain-Barré syndrome can be a devastating disorder because of its sudden and unexpected onset. In addition, recovery is not necessarily quick. As noted above, patients usually reach the point of greatest weakness or paralysis days or weeks after the first symptoms occur. Symptoms then stabilize at this level for a period of days, weeks, or, sometimes, months. The recovery period may be as little as a few weeks or as long as a few years. About 30 percent of those with Guillain-Barré still have a residual weakness after 3 years. About 3 percent may suffer a relapse of muscle weakness and tingling sensations many years after the initial attack.
Guillain-Barré syndrome patients face not only physical difficulties, but emotionally painful periods as well. It is often extremely difficult for patients to adjust to sudden paralysis and dependence on others for help with routine daily activities. Patients sometimes need psychological counseling to help them adapt.
What research is being done?
Scientists are concentrating on finding new treatments and refining existing ones. Scientists are also looking at the workings of the immune system to find which cells are responsible for beginning and carrying out the attack on the nervous system. The fact that so many cases of Guillain-Barré begin after a viral or bacterial infection suggests that certain characteristics of some viruses and bacteria may activate the immune system inappropriately. Investigators are searching for those characteristics. Certain proteins or peptides in viruses and bacteria may be the same as those found in myelin, and the generation of antibodies to neutralize the invading viruses or bacteria could trigger the attack on the myelin sheath. As noted previously, neurological scientists, immunologists, virologists, and pharmacologists are all working collaboratively to learn how to prevent this disorder and to make better therapies available when it strikes.
Saturday, August 15, 2009
A poll carried out for the Public Health Agency of Canada indicates that only 60 per cent of Canadians would choose to take pandemic flu shots.
A poll carried out for the Public Health Agency of Canada indicates that only 60 per cent of Canadians would choose to take pandemic flu shots. Why is the ’swine flu pandemic’ so controversial? Why are so many people vowing they will not be vaccinated? We will talk more about this in a second story about the safety of the H1N1/H5N1 vaccine.
http://columbiavalleynews.com/news/2009/08/14/who-recommends-global-mandatory-vaccination-canada-prepares/
http://columbiavalleynews.com/news/2009/08/14/who-recommends-global-mandatory-vaccination-canada-prepares/
Squalene Adjuvant in Swine Flu Vaccines and Gulf War Syndrome
Micropaleontologist Dr. Viera Scheibner conducted research into the adverse effects of adjuvants in vaccines and wrote: Squalene “contributed to the cascade of reactions called “ Gulf War syndrome. GIs developed arthritis, fibromyalgia, lymphadenopathy, rashes, photosensitive rashes, malar rashes, chronic fatigue, chronic headaches, abnormal body hair loss, non-healing skin lesions, aphthous ulcers, dizziness, weakness, memory loss, seizures, mood changes, neuropsychiatric problems, anti-thyroid effects, anaemia, elevated ESR (erythrocyte sedimentation rate), systemic lupus erythematosus, multiple sclerosis, deadly Amyotrophic Lateral Sclerosis, Raynaud’s phenomenon with paroxysms of lack of blood in fingers and toes in fingers and toes, Sjorgren’s syndrome with blurred vision, chronic diarrhea, night sweats and low-grade fever.”
Wikipedia A study linking squalene, as experimental vaccine adjuvant, to individuals with the clinical signs of Gulf War syndrome was published in 2002. A U.S. Federal Judge ruled that there was good cause to believe aqualene to be harmful, and he ordered the Pentagon to stop administering it in October 2004.
Wikipedia A study linking squalene, as experimental vaccine adjuvant, to individuals with the clinical signs of Gulf War syndrome was published in 2002. A U.S. Federal Judge ruled that there was good cause to believe aqualene to be harmful, and he ordered the Pentagon to stop administering it in October 2004.
Friday, August 14, 2009
According To An MD - Part 1 Of Obama Care
According To An MD - Part 1 Of Obama Care
Was Already Passed Last February!
By Devvy Kidd
8-13-9
......
"The first part of The Obama Health Care Plan was buried in The Stimulus Bill which was signed into law by the President in February (see http://www.readthestimulus.org/ ). It is the second part of The Health Care Plan which is now being debated in Congress.
"Below is the link to the over 1000 page document.....
http://edlabor.house.gov/documents/111/pdf/publications/AAHCA-BillText-071409.pdf
"Let me summarize just a few salient points of the two part Obama Health Care Plan. Warning.......They need to put the same warning on The Obama Health Care Plan as they do a pack of cigarettes.....Consuming this product WILL be hazardous to your health.
"The underlying method of cutting costs throughout the plan is based on rationing and denying care, NOT PREVENTING health care need. The plan's method is the most inhumane and unethical approach in cutting costs. The rationing of care is implemented through a Council, equivalent to the National Health Care Board in the British Health Care System. The name given to this panel is The Federal Coordinating Council For Comparative Effectiveness Research ("Federal Council"). (Section 9201 H.R. 1 Version of the Stimulus Bill.)
"President Obama has already appointed the fifteen member Federal Council. According to the Stimulus Bill, p. 152, all members of the Council must be "senior federal officers or employees." Thus, medical treatment will be dispensed by a group of bureaucrats from their ivory towers, not by the hands-on practitioners in the presence of the patients. The council was funded with $1.1 BILLION from The Stimulus Bill. (http://www.hhs.gov/recovery/programs/os/cerbios.html )
"Comparative Effectiveness Research" is based on the formula of the approval or rejection of treatment for patients based upon the cost per treatment divided by the number of years the patient will benefit from the treatment.
"According to former New York Lieutenant Governor and Health Policy Analyst Dr. Betsy McCaughey, the Federal Council will set a cost effectiveness standard for treatment. (Stimulus Bill p. 464) Translation.....if you are over 65 or have been recently diagnosed as having an advanced form of cardiac disease or aggressive cancer, dream on if you think you will get treated.....pick out your box. Oh, you say...this could never happen. Sorry....this is the same model they use in Britain.
"The plan also empowers the Federal Council to create another level of bureaucracy, The Center for Comparative Effectiveness Research. (Health Care Bill, Section 1181, p. 502). The effect of this extra level of bureaucracy is to slow the development of new medications and technologies in order to reduce costs. How special is that!
"The plan also outlines that doctors and hospitals will be overseen and reviewed by The National Coordinator of Health Information Technology. This "Coordinator" will be responsible for monitoring treatments to make sure doctors and hospitals are strictly following what the government deems appropriate and cost effective, and to "guide medical decisions at the time and place of care." (Stimulus Bill, p. 116; see also pp. 442, 446).
"The Stimulus Bill goes on to say that hospitals and doctors that are NOT "meaningful users" of the new systems will face penalties. The Secretary of Health and Human Services will be empowered to impose "more stringent measures of meaningful use over time." (Stimulus Bill pp. 366, 478, 511, 518, 540, 541.) According to those in Congress, penalties could include large six figure financial fines and possible imprisonment. According to the Obama Plan, if your doctor saves your life but breaks government protocol, you might have to go to the prison to see your doctor for follow -up appointments. I believe this is the same model Stalin used in the former Soviet Union.
"In Section 102 of the Health Care Plan has the Orwellian title: "Protecting the Choice to Keep Current Coverage." What this section really mandates is that it is ILLEGAL for you to keep your private insurance if your status changes, e.g., if you lose or change your job, become a senior citizen, graduate from college and land their first job. Yes, illegal. When President Obama was asked about this portion of his plan recently, his response was, "I am not familiar with that part of the plan."
"Obama hosted a conference call with bloggers urging them to pressure Congress to pass his health plan as soon as possible.
"During the call, a blogger from Maine said he kept running into an Investors Business Daily article that claimed Section 102 of the House health legislation would outlaw private insurance. He asked: "Is this true? Will people be able to keep their insurance and will insurers be able to write new policies even though H.R. 3200 is passed?" President Obama replied: "You know, I have to say that I am not familiar with the provision you are talking about."
"Then there is Section 1233 of the Health Care Bill, devoted to "Advanced Care Planning." After each American turns 65 years of age they have to go to a mandated counseling program that is designed to end life sooner. This session is to occur every 5 years unless the person has developed a chronic illness then it must be done every year. The topics in this government run session will include how to decline hydration, nutrition and how to initiate hospice care. It is no wonder the Obama Administration does NOT like my emphasis on Prevention. Under the Health Care Plan for cost containment, Prevention is the "enemy," since people would live longer.
"I rest my case....The Health Care Plan authored by Obama / Pelosi / Reed is hazardous to the health of every American.
"In the question/answer session following my Capitol Hill presentation, a Congressman asked: "I am doing a number of network interviews next week on the Obama Health Care Plan. If I am asked what is the one word to describe the plan, what should I answer?"
"The answer is simple, honest, direct, analytical, and sad, but truthful. The word is FASCIST.
Dr. Janda is a practicing orthopedic surgeon and a world-recognized expert on prevention, healthcare cost containment, and health care reform.
His website is www.noinjury.com .
Foot notes:
(1) Will you let the federal government take possession of your medical records?
http://www.newswithviews.com/Devvy/kidd435.htm
(2) The American Recovery and Reinvestment Tax Act of 2009
http://www.opencongress.org/bill/111-h1/show
(3) Health Care Reform: Congress Has no Authority to Legislate
http://www.newswithviews.com/Devvy/kidd461.htm
Was Already Passed Last February!
By Devvy Kidd
8-13-9
......
"The first part of The Obama Health Care Plan was buried in The Stimulus Bill which was signed into law by the President in February (see http://www.readthestimulus.org/ ). It is the second part of The Health Care Plan which is now being debated in Congress.
"Below is the link to the over 1000 page document.....
http://edlabor.house.gov/documents/111/pdf/publications/AAHCA-BillText-071409.pdf
"Let me summarize just a few salient points of the two part Obama Health Care Plan. Warning.......They need to put the same warning on The Obama Health Care Plan as they do a pack of cigarettes.....Consuming this product WILL be hazardous to your health.
"The underlying method of cutting costs throughout the plan is based on rationing and denying care, NOT PREVENTING health care need. The plan's method is the most inhumane and unethical approach in cutting costs. The rationing of care is implemented through a Council, equivalent to the National Health Care Board in the British Health Care System. The name given to this panel is The Federal Coordinating Council For Comparative Effectiveness Research ("Federal Council"). (Section 9201 H.R. 1 Version of the Stimulus Bill.)
"President Obama has already appointed the fifteen member Federal Council. According to the Stimulus Bill, p. 152, all members of the Council must be "senior federal officers or employees." Thus, medical treatment will be dispensed by a group of bureaucrats from their ivory towers, not by the hands-on practitioners in the presence of the patients. The council was funded with $1.1 BILLION from The Stimulus Bill. (http://www.hhs.gov/recovery/programs/os/cerbios.html )
"Comparative Effectiveness Research" is based on the formula of the approval or rejection of treatment for patients based upon the cost per treatment divided by the number of years the patient will benefit from the treatment.
"According to former New York Lieutenant Governor and Health Policy Analyst Dr. Betsy McCaughey, the Federal Council will set a cost effectiveness standard for treatment. (Stimulus Bill p. 464) Translation.....if you are over 65 or have been recently diagnosed as having an advanced form of cardiac disease or aggressive cancer, dream on if you think you will get treated.....pick out your box. Oh, you say...this could never happen. Sorry....this is the same model they use in Britain.
"The plan also empowers the Federal Council to create another level of bureaucracy, The Center for Comparative Effectiveness Research. (Health Care Bill, Section 1181, p. 502). The effect of this extra level of bureaucracy is to slow the development of new medications and technologies in order to reduce costs. How special is that!
"The plan also outlines that doctors and hospitals will be overseen and reviewed by The National Coordinator of Health Information Technology. This "Coordinator" will be responsible for monitoring treatments to make sure doctors and hospitals are strictly following what the government deems appropriate and cost effective, and to "guide medical decisions at the time and place of care." (Stimulus Bill, p. 116; see also pp. 442, 446).
"The Stimulus Bill goes on to say that hospitals and doctors that are NOT "meaningful users" of the new systems will face penalties. The Secretary of Health and Human Services will be empowered to impose "more stringent measures of meaningful use over time." (Stimulus Bill pp. 366, 478, 511, 518, 540, 541.) According to those in Congress, penalties could include large six figure financial fines and possible imprisonment. According to the Obama Plan, if your doctor saves your life but breaks government protocol, you might have to go to the prison to see your doctor for follow -up appointments. I believe this is the same model Stalin used in the former Soviet Union.
"In Section 102 of the Health Care Plan has the Orwellian title: "Protecting the Choice to Keep Current Coverage." What this section really mandates is that it is ILLEGAL for you to keep your private insurance if your status changes, e.g., if you lose or change your job, become a senior citizen, graduate from college and land their first job. Yes, illegal. When President Obama was asked about this portion of his plan recently, his response was, "I am not familiar with that part of the plan."
"Obama hosted a conference call with bloggers urging them to pressure Congress to pass his health plan as soon as possible.
"During the call, a blogger from Maine said he kept running into an Investors Business Daily article that claimed Section 102 of the House health legislation would outlaw private insurance. He asked: "Is this true? Will people be able to keep their insurance and will insurers be able to write new policies even though H.R. 3200 is passed?" President Obama replied: "You know, I have to say that I am not familiar with the provision you are talking about."
"Then there is Section 1233 of the Health Care Bill, devoted to "Advanced Care Planning." After each American turns 65 years of age they have to go to a mandated counseling program that is designed to end life sooner. This session is to occur every 5 years unless the person has developed a chronic illness then it must be done every year. The topics in this government run session will include how to decline hydration, nutrition and how to initiate hospice care. It is no wonder the Obama Administration does NOT like my emphasis on Prevention. Under the Health Care Plan for cost containment, Prevention is the "enemy," since people would live longer.
"I rest my case....The Health Care Plan authored by Obama / Pelosi / Reed is hazardous to the health of every American.
"In the question/answer session following my Capitol Hill presentation, a Congressman asked: "I am doing a number of network interviews next week on the Obama Health Care Plan. If I am asked what is the one word to describe the plan, what should I answer?"
"The answer is simple, honest, direct, analytical, and sad, but truthful. The word is FASCIST.
Dr. Janda is a practicing orthopedic surgeon and a world-recognized expert on prevention, healthcare cost containment, and health care reform.
His website is www.noinjury.com .
Foot notes:
(1) Will you let the federal government take possession of your medical records?
http://www.newswithviews.com/Devvy/kidd435.htm
(2) The American Recovery and Reinvestment Tax Act of 2009
http://www.opencongress.org/bill/111-h1/show
(3) Health Care Reform: Congress Has no Authority to Legislate
http://www.newswithviews.com/Devvy/kidd461.htm
Thursday, August 13, 2009
Specific Pesticide Directly Linked to Parkinson's Disease
Specific Pesticide Directly Linked to Parkinson's Disease
Friday, August 14, 2009 by: S. L. Baker, features writer
Key concepts: Disease, Parkinson's and Pesticides
View on NaturalPedia: Disease, Parkinson's and Pesticides
(NaturalNews) According to the National Parkinson Foundation, about 1.5. Americans currently have Parkinson's Disease (PD) -- the motor system disorder which afflicts actor Michael J. Fox. Another 60,000 or so people in the U.S. will be diagnosed with PD in 2009. The four main symptoms of this often devastating disease are trembling in the hands, arms, legs, jaw, and face; rigidity, or stiffness of the limbs and trunk; bradykinesia (slowness of movement) and impaired balance and coordination. As the disease progresses, people with PD may have difficulty walking, talking, and swallowing.
NaturalNews has previously reported (http://www.naturalnews.com/026177_d...) how research is pointing more and more to a "smoking gun" behind Parkinson's. It appears PD doesn't just strike at random. Instead, it is most likely triggered by chemicals in the environment that are literally toxic to the human brain. Now a new study has zeroed in on one specific suspect -- a pesticide called B-hexachlorocyclohexane (B-HCH).
Friday, August 14, 2009 by: S. L. Baker, features writer
Key concepts: Disease, Parkinson's and Pesticides
View on NaturalPedia: Disease, Parkinson's and Pesticides
(NaturalNews) According to the National Parkinson Foundation, about 1.5. Americans currently have Parkinson's Disease (PD) -- the motor system disorder which afflicts actor Michael J. Fox. Another 60,000 or so people in the U.S. will be diagnosed with PD in 2009. The four main symptoms of this often devastating disease are trembling in the hands, arms, legs, jaw, and face; rigidity, or stiffness of the limbs and trunk; bradykinesia (slowness of movement) and impaired balance and coordination. As the disease progresses, people with PD may have difficulty walking, talking, and swallowing.
NaturalNews has previously reported (http://www.naturalnews.com/026177_d...) how research is pointing more and more to a "smoking gun" behind Parkinson's. It appears PD doesn't just strike at random. Instead, it is most likely triggered by chemicals in the environment that are literally toxic to the human brain. Now a new study has zeroed in on one specific suspect -- a pesticide called B-hexachlorocyclohexane (B-HCH).
Subscribe to:
Posts (Atom)